Recently, Guo et al. found that miR-410 acts as a TSmiR which suppresses pancreatic cancer growth, cell invasion, migration and angiogenesis by targeting angiotensin II type 1 receptor (AGTR1) [78]. The gene discussed is AGTR1; the disease is pancreatic neoplasm.